🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
JNJ
NYSE
🇺🇸 US
Johnson & Johnson
Healthcare
26Score
DipBuster Score™
$265.56
+$7.78 (+3.02%)
Live price · Source: Yahoo
52-Week Position
$184.66
84% of range
$281.07
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$281.07
52W Low$184.66
DipBuster Brief
Key signals at a glance
Zone: Consider Trimming
Bearish
Near 52-Week High — Asymmetric Risk
At 84% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position84% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Johnson & Johnson (JNJ), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-09-08 | Woods Eugene A. | BUY | 136 |
| 2026-09-08 | Pinto Daniel E | BUY | 113 |
| 2026-09-08 | Hewson Marillyn A | BUY | 181 |
| 2026-09-02 | Schmid Timothy | SELL | 22,527 |
| 2026-09-02 | Schmid Timothy | SELL | 11,070 |
| 2026-09-02 | Schmid Timothy | SELL | 22,527 |
| 2026-09-02 | Schmid Timothy | BUY | 22,527 |
| 2026-09-02 | Schmid Timothy | SELL | 11,070 |
| 2026-09-02 | Schmid Timothy | BUY | 11,070 |
| 2026-08-17 | Taubert Jennifer L | SELL | 15,000 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$281.07
52W Low$184.66
52-Week Range
$184.66Now$281.07
84% through annual range
From 52W High−5.5%
From 52W Low+43.8%
📖 Plain English Summary
Johnson & Johnson is at 84% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for JNJ
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — JNJ
Heuristic · balance sheet, insider filings, price data, academic research
Johnson & Johnson — DipBuster Score 26/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Johnson & Johnson free
Add JNJ to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
6/25
Momentum & Volume
15/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
1
/100 · NEUTRAL
dip depth
1/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Insiders' avg buy price: $206.15 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 26/100
📈
Strong recent momentum — price and volume trending in the right direction.